In summary, utilizing a high-multiplex immunoassay analysis of serum proteins from patient-matched pre-operative and post-operative serum samples from ten men with high-grade and high-volume prostate cancer, we identified CASP8 as a promising potential protein biomarker for detection high-risk prostate cancer. This evidence concerns the gene CASP8 and prostate cancer.